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Abstract  24	
The regulation of chromatin structure is critical for a wide range of essential cellular processes. 25	
The Tousled like kinases, TLK1 and TLK2, regulate ASF1, a histone H3/H4 chaperone, and 26	
likely other substrates, and their activity has been implicated in transcription, DNA replication, 27	
DNA repair, RNA interference, cell cycle progression, viral latency, chromosome segregation 28	
and mitosis. However, little is known about the functions of TLK activity in vivo or the relative 29	
functions of the highly similar TLK1 and TLK2 in any cell type. To begin to address this, we 30	
have generated Tlk1 and Tlk2 deficient mice. We found that while TLK1 was dispensable for 31	
murine viability, TLK2 loss led to late embryonic lethality due to placental failure. TLK2 was 32	
required for normal trophoblast differentiation and the phosphorylation of ASF1 was reduced 33	
in placentas lacking TLK2. Conditional bypass of the placental phenotype allowed the 34	
generation of apparently healthy TLK2 deficient mice, while only the depletion of both TLK1 35	
and TLK2 led to extensive genomic instability, indicating that both activities contribute to 36	
genome maintenance. Our data identifies a specific role for TLK2 in placental function during 37	
mammalian development and suggests that TLK1 and TLK2 play largely redundant roles in 38	
genome maintenance.  39	
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Introduction 40	
The Tousled kinase (TSL) and Tousled-like kinases (TLKs) are serine-threonine kinases 41	
whose activity has been linked to DNA replication, DNA repair, transcription, chromatin 42	
structure, chromosome segregation, RNA interference, viral latency and cell cycle checkpoint 43	
control in various organisms(1-9). TSL was identified in Arabidopsis where mutations in the 44	
gene led to pleiotropic defects, including delays in flowering time and leaf development(1). In 45	
Drosophila and C.elegans, deficiency in the single TLK gene led to severe mitotic defects and 46	
lethality during development(8, 10). In Drosophila, these effects were proposed to result from 47	
defective chromatin maintenance and could be rescued by the overexpression of the histone 48	
H3-H4 chaperone ASF1, a substrate of TLK(3, 10). In C.elegans, the major defects observed 49	
following ceTLK-1 downregulation were transcriptional, reflecting reduced phosphorylation of 50	
RNA polymerase II, and mitotic, through interactions with Aurora B(7, 8). 51	
Vertebrates encode 2 distinct TLK homologues, Tousled like kinases 1 and 2 (TLK1 and 52	
TLK2), that interact with each other and both ASF1a and ASF1b (3). In Drosophila, TLK 53	
phosphorylation of ASF1 controls its stability, while in vertebrates, TLK1 mediated 54	
phosphorylation of several sites on the C-terminal tail of ASF1 promote its binding affinity for 55	
the H3-H4 heterodimer(11, 12). Following DNA damage, TLK1 is phosphorylated by the 56	
checkpoint kinase CHK1, inhibiting its activity, potentially to coordinate global ASF1 histone 57	
binding capacity with the checkpoint response(13, 14). TLK activity has also been linked to 58	
cell cycle checkpoint recovery through the phosphorylation of RAD9, a component of the 9-1-59	
1 (RAD9/HUS1/RAD1) alternative clamp loader that plays multiple roles in the response to 60	
DNA damage, including the regulation of CHK1 activation(15-17), and through TLK2-ASF1a 61	
mediated transcriptional events(18). Although TLK2 is less well characterized, the 62	
amplification of its activity has been specifically linked to breast cancer progression in recent 63	
work(19, 20).  64	
Despite their identification nearly 15 years ago, the roles of the ubiquitously expressed TLK1 65	
and TLK2 in mammalian physiology remain unexplored. In particular, whether they have 66	
distinct, overlapping or entirely redundant roles in particular tissues or cell types, remains 67	
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unknown. Here we describe the generation and characterization of both Tlk1 and Tlk2 68	
deficient mice and cells that reveal distinct and redundant roles for TLK1 and TLK2 activities 69	
in development and genome maintenance.  70	
Results 71	
TLK1 is dispensable for embryogenesis and murine viability 72	
To determine if TLK1 and TLK2 had distinct or redundant roles during development or aging, 73	
we generated mice deficient for either Tlk1 or Tlk2. Mice homozygous for a gene-trapped 74	
allele of Tlk1 (Tlk1T) (Figure 1A and B) showed efficient reduction of Tlk1 expression (Figure 75	
1C). In addition, no TLK1 protein was detectable in Westerns from embryonic fibroblast (MEF) 76	
lysates (Figure 1D) and no compensatory changes in Tlk2 mRNA or protein levels were 77	
evident (Figure 1C and D). Despite the implication of TLK1 in many critical cellular processes, 78	
Tlk1T/T mice were born at normal Mendelian ratios (Figure 1E) and showed no obvious 79	
morphological or size differences at birth or during the first months of development (Figure 80	
1F)(4, 13-16, 21-23). In addition, Tlk1T/T mice did not exhibit any obvious developmental 81	
phenotypes or accelerated morbidity over 18 months (Figure 1G). Both male and female 82	
Tlk1T/T mice were fertile, indicating that meiotic recombination was largely functional, and 83	
Tlk1T/T females produced litter sizes similar to that of Tlk1+/+ and Tlk1+/T littermates (Figure 84	
1H). Additionally, we examined T-cell development that requires the repair of DNA double-85	
strand breaks (DSBs) induced by the RAG recombinase, as previous work has implicated 86	
TLK1 in DNA repair(16, 21-24). Similar to what was observed in MEFs, no TLK1 protein was 87	
detectable in T-cells from Tlk1T/T mice (Figure 1I) and the distribution of T-cells in Tlk1+/+ and 88	
Tlk1T/T deficient mice was indistinguishable (Figure 1J), indicating that non-homologous end-89	
joining (NHEJ) mediated DNA repair in this tissue operates efficiently in the absence of TLK1. 90	
While we cannot rule out more subtle effects on repair processes or developmental programs, 91	
these data indicated that TLK1 was dispensable for murine development, aging and multiple 92	
physiological DNA repair events. 93	
TLK2 is an essential gene 94	
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Based on previous data from lower organisms, we expected that loss of TLK1 activity would 95	
result in severe phenotypes in the mouse (8, 10). The lack of any clear phenotypes in Tlk1T/T 96	
animals suggested potentially redundant activities, with TLK2 being the most likely candidate. 97	
To address this, we generated a conditional, gene-trapped allele of Tlk2 (Figure 2A, 2B and 98	
Supplementary Figure S1) and interbred heterozygous mice to generate Tlk2 deficient 99	
animals. In sharp contrast to Tlk1, we did not observe any live births of Tlk2T/T mice, indicating 100	
embryonic lethality (Figure 2C).  101	
To understand the cause of death, we examined embryos at different developmental stages. 102	
The number of Tlk2T/T embryos observed from E10.5 to E13.5 was consistent with expected 103	
Mendelian ratios (Figure 2D), although embryos were smaller in all cases (Figure 2E to H). 104	
Tlk2T/T embryos appeared anemic (Figure 2F and G) and perished by E15.5, as no heartbeat 105	
was detectable. By E16.5 extensive tissue autolysis was evident (Figure 2H). Fibroblast 106	
cultures from E14.5 embryos confirmed that Tlk2 mRNA and protein levels were reduced and 107	
that there was no compensatory increase of TLK1 (Figure 2I and J). The further examination 108	
of Tlk2T/T embryos by conventional immunohistochemistry (IHC) (Figure 2K) and lightsheet-109	
based fluorescence macroscopy (Supplementary Figure S2) did not reveal any consistent 110	
defects and suggested that embryos were developmentally delayed, but in the majority of 111	
cases morphologically normal. Collectively, our data suggested that TLK2, but not TLK1, was 112	
essential for embryonic viability. 113	
TLK2 is essential for placental development 114	
As consistent defects in embryonic morphology were not observed, we examined placental 115	
function. At E14.5 Tlk2T/T placentas were smaller and there was a lack of blood circulation in 116	
the umbilical cord (Supplementary Figures S3A and S3B). To address this phenotype further 117	
without potential complications from the genetrap, we excised it by crossing to FlpO 118	
expressing mice, thus rendering Exon 4 floxable (Tlk2F)(Figure 2A). Crosses with mice 119	
expressing Sox2-Cre, that is active in the embryonic epiblast cells, effectively deleted Exon 4 120	
and yielded Tlk2+/- animals that were then interbred to generate Tlk2-/- embryos 121	
(Supplementary Figure S3C).   122	
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We histologically examined Tlk2-/- placentas from embryonic days E10.5 to E16.5 and at all 123	
stages, Tlk2-/- placentas were moderately to severely smaller, thinner and less cellular 124	
compared to Tlk2+/+ or Tlk2+/- littermates, and poorly vascularized (Figure 3A to 3E and 125	
Supplementary Figure S3). At E10.5 through E12.5 the labyrinths of Tlk2-/- placentas were 126	
disorganized and composed of less differentiated and less mature trophoblasts (Figure 3D 127	
and Supplementary Figure S3). Tlk2-/- placentas had moderately to severely reduced 128	
numbers of labyrinth trophoblast, syncytiotrophoblast, spongiotrophoblast (including glycogen 129	
cells) and mildly to moderately reduced numbers of trophoblastic giant cells and vasculature 130	
(Figure 3C, 3D, 3E and Supplementary Figure S3). These data indicated that TLK2 was 131	
required for normal placental development and function, and that its loss led to late embryonic 132	
lethality 133	
The influence of TLK2 deficiency on proliferation and gene expression in the placenta  134	
As the regulation of ASF1 by TLK activity has been linked to ongoing DNA replication, we 135	
examined trophoblast proliferation by IHC using the marker Ki67 (2). By E12.5 most cells of 136	
the trophoblastic lineage are differentiated and their rate of proliferation decreases (25, 26). 137	
Regardless of genotype, we observed similar percentages of Ki67 positive cells at each stage 138	
of development suggesting that the overall number of proliferating cells was similar (Figure 139	
4A). In addition, we did not observe any significant increase in either the DNA double strand 140	
break marker γH2AX or the apoptosis marker cleaved caspase 3 (CC3) (Figure 4B and 141	
Supplementary Figure S4A), suggesting that overall levels of proliferation, DNA damage, and 142	
cell death were similar. 143	
In addition to DNA replication, TLK2 has been implicated in transcriptional regulation through 144	
the phosphorylation of ASF1a (18, 27). To address the possibility that transcription may be 145	
affected, we examined the mRNA expression levels of several genes required for trophoblast 146	
differentiation; Cdx2, Tpbpa, Pl1 and Pl2 (28). We observed lower levels of Cdx2, Tpbpa, and 147	
Pl2 in the Tlk2-/- placentas, reflecting reduced numbers and/or defective differentiation of 148	
trophoblast stem cells, spongiotrophoblasts and canal or sinusoidal trophoblast giant cells, 149	
respectively (Figure 4C). In contrast, the expression of Pl1, that is a marker for parietal 150	
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trophoblast giant cells and is normally reduced by E11.5, was slightly upregulated compared 151	
to wild type placenta, although this was more variable amongst individual samples (Figure 152	
4C)(28). In addition, the expression of many imprinted genes that influence placental 153	
development, including Igf2, H19, Peg10 and Grb10, was reduced in Tlk2-/- placentas, while 154	
others, such as IgfR2 and Phlda2, were expressed at similar levels to that of wild type (Figure 155	
4D)(28, 29). The reduced size of the Tlk2-/- labyrinth and reduced area of Tpbpa positive cells 156	
was further confirmed with IHC (Figure 4E). Together, these data suggested that the loss of 157	
TLK2 did not cause clear defects in trophoblast proliferation or survival, but reduced the 158	
expression of numerous genes important for their normal function and led to impaired 159	
differentiation and placental function. 160	
TLK2 interacts with ASF1 and influences its phosphorylation in the placenta 161	
To understand why placental function was dependent on TLK2 and not TLK1, we examined 162	
their relative mRNA expression and protein levels. We found similar mRNA expression 163	
patterns of both genes in the wild type placenta at E13.5, E15.5 and E17.5 (Figure 5A). The 164	
protein levels of TLK2 were similar in placental tissue compared to tissue from the embryo 165	
(heart and fetal liver), while TLK1 protein levels were strongly increased in the embryonic 166	
tissues compared to the placenta, although TLK1 was detectable in placentas (Figure 5B and 167	
Supplementary Figure S4B). This suggested that TLK1 was significantly less abundant in the 168	
placenta than the embryo, providing a potential explanation as to why placental development 169	
was particularly sensitive to Tlk2 deficiency. 170	
ASF1a and ASF1b are the most clearly defined targets of TLK1 and TLK2 but other 171	
substrates, such as RAD9 and NEK1, have been reported for TLK1(15, 23, 30). To address 172	
the potential substrate spectrum of TLK2, we carried out immunoprecipitations of tagged 173	
TLK2 or kinase dead TLK2 (TLK2-KD) followed by quantitative mass spectrometry (IP-MS, 174	
Supplementary Figure S5A). In addition, we overexpressed TLK2 fused to the BirA* biotin 175	
ligase to identify the proximity interactome of TLK2 using BioID (Supplementary Figure S5B). 176	
Only a small number of proteins were consistently identified by both approaches, including 177	
ASF1a and ASF1b, TLK1 and LC8 (DYNLL1) (Figure 5C, Supplementary Figure S5 and 178	
	 8	
Supplementary Tables S1-S6). Additional proteins known to be involved in a variety of cellular 179	
processes, including DNA replication and chromatin assembly (ex. MCM helicase 180	
components, RIF1 and HIRA/UBN1-2), transcription (ex. GATAD2A, JUN) and translation (ex. 181	
EIF3F, EIF2S1) were identified in one or both approaches below our statistical thresholds 182	
(Figure 5C). We focused on the most high confidence interactions and found that while we 183	
could confirm the LC8 interaction, it did not appear to be a substrate of TLK2 activity 184	
(Supplementary Figure S5E-H). We therefore focused on determining the level and 185	
phosphorylation status of ASF1 in normal and Tlk2 deficient placentas. In Tlk2-/- placentas 186	
total ASF1 protein levels were similar to wild type controls but the phosphorylation of S166 (p-187	
ASF1), a target site of TLKs, was reduced, suggesting reduced H3/H4 binding potential in the 188	
absence of TLK2 (Figure 5D and Supplementary Figure S6A)(11). To confirm the interaction 189	
of TLK2 with ASF1 in the placenta, we performed co-immunoprecipitations (IPs) of 190	
endogenous TLK2 or ASF1 from placental lysates. Following the IP of TLK2, we readily 191	
observed both ASF1 and TLK1 and reciprocal IPs with anti-ASF1 antibodies efficiently co-IPd 192	
TLK2 (Figure 5E and Supplementary Figure S6B). Together, these results indicated that 193	
despite some levels of detectable TLK1, TLK2 is required for full ASF1 phosphorylation in the 194	
placenta, potentially influencing the regulation of genes required for trophoblast differentiation 195	
and placental development.  196	
TLK2 is dispensable for viability in embryonic and adult tissues 197	
The differential protein levels of TLK1 between the placenta and embryonic tissue provided a 198	
potential explanation for placental dependence on TLK2 (Figure 5B). We considered that a 199	
similar situation in other cell types in the embryo could also contribute to the embryonic death 200	
of Tlk2-/- animals. To address this, we crossed female Tlk2+/- mice carrying the Sox2-Cre 201	
transgene, that expresses Cre in the epiblast, with males carrying the floxed conditional allele 202	
(Tlk2+/F) to allow the generation of Tlk2-/- embryos, while maintaining at least 1 functional copy 203	
of Tlk2 in the placenta (Figure 6A)(31). This strategy bypassed the embryonic lethality and we 204	
observed the birth of live, morphologically normal, Tlk2-/- animals (Figure 6A). These animals, 205	
although sometimes smaller than littermates, showed a similar growth capacity (Figure 6B) 206	
and no increased morbidity has been observed up to 18 months (Figure 6C), although we 207	
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cannot yet rule out tissue specific or aging related phenotypes that are not overtly evident. 208	
Importantly, we could not detect TLK2 protein in any tissues examined by Western blotting, 209	
indicating that Sox2-Cre was effective at eliminating Tlk2 expression (Figure 6D). These data 210	
demonstrate that, like TLK1, TLK2 is not required for organismal viability, despite its critical 211	
role in the development and function of the placenta. 212	
As relative TLK1 and TLK2 protein levels were different between embryonic and placental 213	
tissues, we sought to determine if a similar situation existed in other adult tissues. We freshly 214	
isolated mRNA and protein from a panel of wild type tissues at 2 months of age. Using 215	
quantitative real time PCR we determined the expression levels of Tlk1 and Tlk2 in different 216	
tissues (Figure 6E). In general, the expression of Tlk1 and Tlk2 followed a similar pattern 217	
across tissues, although the expression of Tlk2 was particularly high in the testes, where the 218	
human TLK2 gene was originally identified (6). To determine if the mRNA levels reflected 219	
relative protein levels, we performed Western blotting from lysates prepared from some of the 220	
same tissues of both male and female mice (Figure 6F). These results were generally 221	
consistent with the mRNA expression levels and the patterns of TLK1 and TLK2 protein levels 222	
were similar relative to tissue type. One exception was the kidney, where both TLK1 and 223	
TLK2 protein were undetectable, despite similar levels of mRNA expression as other tissues 224	
(Figure 6E and 6F). These results suggested that the lack of clear phenotypes in adult 225	
animals deficient for either TLK1 or TLK2 could be due to their redundancy in most tissues, in 226	
contrast to the placenta where TLK2 is required due to the low levels of TLK1. Supporting this 227	
possibility, we found that Tlk2 is haploinsufficient on a Tlk1 deficient background, as all Tlk1T/T 228	
Tlk2+/T pups we observed displayed severe birth defects (Figure 6G and Supplementary 229	
Figure S7). 230	
TLK1 and TLK2 cooperate to maintain cell viability and chromosomal stability 231	
As TLK1 or TLK2 deficient animals appeared phenotypically normal, we wanted to investigate 232	
the effects of depleting both activities. To accomplish this, we generated single (Tlk1+/+Tlk2F/-) 233	
and double conditional (Tlk1C/CTlk2F/-) transformed MEF lines that allow the 4-234	
hydroxytamoxifen (4OHT) inducible trapping and deletion of Tlk1 and Tlk2, respectively. 235	
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Depletion of TLK1 and TLK2 protein levels following 4OHT induced Cre recombinase 236	
induction was effective (Figure 7A) and led to reduced colony formation compared to wild type 237	
or single mutants for Tlk2 (Figure 7B). 238	
The simultaneous depletion of TLK1 and TLK2 resulted in a marked increase in DNA double-239	
strand breaks, indicated by increased intensity of γH2AX foci in the nucleus (Figure 7C and 240	
7D). These cells also displayed mitotic defects, such as chromosome bridges (Figure 7E), as 241	
well as increased levels of chromosome aberrations scored in metaphase spreads, 242	
particularly chromosome fragments and fusions (Figure 7F). This was accompanied by a 243	
reduction in total ASF1 phosphorylation, similar to what was observed in the placenta (Figure 244	
7G). Collectively, our in vivo and in vitro results indicated that TLK1 and TLK2 activities are 245	
largely redundant for cell viability and chromosome maintenance, but that TLK2 is critical for 246	
mammalian development through its role in supporting placental function (Figure 7H). 247	
Discussion 248	
Here we describe for the first time, the relative contributions of TLK1 and TLK2 to mammalian 249	
embryogenesis. Of the 2 proteins, TLK1 has been the most studied and has been implicated 250	
in many critical cellular processes, such as transcription, DNA repair, DNA replication and 251	
mitosis(2, 4, 7, 8, 10, 11, 13-16, 21-23, 32-36). While it may play a role directly or indirectly in 252	
these processes, our results indicate that TLK1 is not required for essential cellular functions 253	
when TLK2 is expressed normally. We did however observe that TLK1 becomes essential in 254	
Tlk2+/T animals, (Figure 6G) and we believe that this likely reflects a need for TLK1 in 255	
supporting placental, or possibly embryonic function, when Tlk2 is haploinsufficient, but have 256	
not investigated this further. Regardless, the loss of TLK1 does not impair the generation of 257	
viable, apparently healthy animals, notably impact several physiological repair processes or 258	
detectably influence genomic stability. 259	
In contrast to TLK1, TLK2 was strictly required for embryogenesis through its role in 260	
supporting placental development. As both Tlk1 and Tlk2 mRNAs are readily detectable in 261	
every tissue that we (Figure 6E), and others (37), have examined, this essential role for TLK2 262	
was unexpected. We observed reduced ASF1 phosphorylation, impaired gene expression 263	
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and histological evidence that indicated a requirement for TLK2 in the proper differentiation of 264	
the trophoblast lineages. As we did not observe any indications that proliferation was strongly 265	
affected, we believe this is likely through a role in transcriptional regulation(18). We however, 266	
cannot rule out the possibility that loss of TLK2 impairs DNA replication to some extent, 267	
leading to either cellular attrition or indirect defects on transcription and that TLK2 may 268	
influence cell migration(19) or other cellular functions that have yet to be uncovered. A similar 269	
differential requirement for ASF1a and ASF1b in development has been previously reported. 270	
The depletion of murine ASF1a leads to lethality by E9.5(38), notably earlier than we 271	
observed with TLK2 deletion, potentially consistent with the incomplete effect we observed on 272	
total ASF1 phosphorylation. In contrast, ASF1b is dispensable for viability, although it affects 273	
fertility(39). While mice lacking either TLK1 or TLK2 were fertile, we cannot rule out subtle or 274	
age related differences in fertility from existing data. Future analysis of mice lacking 275	
combinations of both TLK and ASF1 alleles may be informative for identifying more specific 276	
functions and determining how much of the TLK deficient phenotype relies on ASF1 277	
regulation. 278	
Although mRNA levels of Tlk1 and Tlk2 were similar from E13.5 to 17.5 of placental 279	
development, TLK1 protein levels were much higher in embryonic tissues compared to 280	
placenta, while TLK2 protein levels were similar regardless of the tissue. We believe this 281	
provides the most parsimonious explanation for the essential nature of TLK2 in the placenta, 282	
although we cannot rule out that TLK2 is uniquely capable of modifying a cell type specific 283	
substrate or carrying out another unknown, essential role during development. Whether 284	
similar unique dependencies of either TLK1 or TLK2 occur in other cell types of embryonic or 285	
adult animals remains to be determined, as do the mechanisms that regulate TLK1 or TLK2 286	
protein levels, activity and substrate engagement.  287	
TLK1 activity appears to buffer Tlk2 haploinsufficiency (Figure 6G), but it is insufficient to fully 288	
support placental development in the absence of TLK2. This may be due to its lower levels, 289	
and presumably lower activity, relative to embryonic tissue, reduced affinity for ASF1a(27), or 290	
due to specific interactions that have yet to be identified. However, in other tissues of the 291	
embryo and adult animals, the protein levels of TLK1 and TLK2 appear to be sufficient to act 292	
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interchangeably to support cellular functions, evidenced by the viability of both Tlk1T/T and 293	
Tlk2-/- cell cultures and animals (Figures 1, 6 and 7).  294	
While our results suggest that there may be a high level of redundancy between TLK1 and 295	
TLK2 in many cell types, recent work has specifically connected TLK2 mutations to patients 296	
with intellectual disabilities(40) and it is tempting to speculate that this could reflect placental 297	
defects, although we would expect them to be less dramatic than what we have observed in 298	
mice with a full TLK2 knockout. Moreover, TLK2 has been identified as a regulator of 299	
starvation induced autophagy(41) and gammaherpesvirus latency(9), amplifications and 300	
hyperphosphorylation of specifically TLK2 have been identified in subtypes of breast cancer 301	
and shown to influence cancer progression(19, 20, 42, 43) and TLK2 has been shown to play 302	
a critical role in cell cycle checkpoint recovery that was not observed following TLK1 303	
depletion(18). These apparently specific roles may reflect differences in their transcriptional or 304	
translational regulation and relative ratios, differential control of their activity or distinct 305	
substrate specificity. Recent work identified around 150 putative TLK1 interactors(30) and we 306	
found only 7 proteins in common using different experimental approaches for TLK2, including 307	
ABLIM1, DNAJC7, EMG1, PDCD6, SERBP1, SNRPC and SRSF1, although these fell below 308	
the stringent thresholds we used for selecting interactions to validate (Figure 5C and 309	
Supplementary Tables S1-S6). Further investigation in a wider array of cell types will be 310	
required to understand the unique and overlapping substrates and functions of TLK1 and 311	
TLK2 and their specific roles in development, genome maintenance and other cellular 312	
processes.  313	
Materials and Methods  314	
Generation of Tlk1 and Tlk2 deficient mice 315	
Embryonic stem (ES) cells with a gene-trapped Tlk1 allele were purchased from the German 316	
Genetrap Consortium (clone ID E067A02). A single insertion was confirmed and cells injected 317	
into 3.5-day mouse C57B6/j blastocysts (Fig. S1). 12-15 ES cells were injected into each 318	
blastocyst and re-implanted into the oviduct of 2.5-day pseudo-pregnant foster mice (CD1s). 319	
Chimeras were scored and mated with C57B6/j wild-type mice. Agouti offspring were 320	
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screened by PCR for the Tlk1 allele and pups were screened for zygosity using PCR or by 321	
quantitative real time PCR (Transnetyx). Primer details available upon request.  322	
 323	
The knockout-first Tlk2 targeting construct was designed and constructed in the IRB Mutant 324	
Mouse facility using standard recombineering methods(44). The targeting vector was 325	
confirmed by sequencing and linearized vector transfected into ES cells for targeting. Cells 326	
were selected with neomycin and digested genomic DNA analyzed by Southern blot 327	
(performed by service in the Centro Ricerche Biotecnologiche of the Università Cattolica del 328	
Sacro Cuore) for correct targeting (Fig. S1). For Southern analysis, 3 probes were used and 329	
correctly targeted clones injected as described for Tlk1. We analyzed the 5' (5P) and 3' (3P) 330	
integration sites following KpnI digestion (probe primers in Table S7). Pgk1-FlpO (011065), 331	
Sox2-Cre (008454) were purchased from Jackson laboratories and ERT2-Cre mice were 332	
previously described (31, 45, 46). All animals were maintained in strict accordance with the 333	
European Community (86/609/EEC) guidelines at the animal facilities in the Barcelona 334	
Science Park (PCB). Protocols (CEAA13/0008) were approved by the Animal Care and Use 335	
Committee of the PCB (IACUC; CEEA-PCB) in accordance with applicable legislation (Law 336	
5/1995/GC; Order 214/1997/GC; Law 1201/2005/SG). All efforts were made to minimize use 337	
and suffering. 338	
Generation of mouse embryonic fibroblasts (MEFs) 339	
Mouse embryonic fibroblasts (MEFs) cultures were established from E14.5 embryos that were 340	
dissected into fresh PBS and kept overnight at 4ºC in trypsin/EDTA (Life Technologies) 341	
solution. Following incubation at 37ºC for 20 minutes, cells were disaggregated with a 342	
serological pipette and supernatant plated for culture in DMEM supplemented with 10% (v/v) 343	
fetal bovine serum (FBS, Sigma), 2mM L-glutamine and 100 U/ml penicillin. Transformed 344	
MEFs were generated by transfecting a linearized p129 plasmid, containing an origin-less 345	
SV40 genome, using an Amaxa nucleofector with MEF reagent 2 (Amaxa). For the induction 346	
of Cre recombinase in ERT2-Cre expressing cell lines, cells were exposed to 4-347	
hydroxytamoxifen (Sigma H7904, 1uM) for 72h, washed, and plated for experiments.  348	
Immunological analysis 349	
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Analysis of thymocytes was performed as described previously(47). Thymi were dissected 350	
from 8-week old animals and a single-cell suspension was obtained using a 45 µm nylon 351	
mesh (Falcon). Apoptosis of thymoctes was assessed by flow cytometry after double staining 352	
with FITC-conjugated Annexin V (BD Biosciences) and propidium iodide. Thymic 353	
subpopulations were quantified by staining with fluorescence-conjugated antibodies for CD3e, 354	
CD4 and CD8 (BD Biosciences) and analysis by flow cytometry using FlowJo software (Tree 355	
Star).  356	
Immunohistochemistry (IHC) 357	
Paraffin-embedded tissue sections (3 µm) were air dried and further dried at 60ºC over-night. 358	
IHC was performed using an Autostainer Plus (Dako-Agilent) or manually (Tpbpa). Prior to 359	
IHC, sections were dewaxed using the low pH EnVision™ FLEX Target Retrieval Solutions 360	
for caspase 3 detection (Dako, Burlington) for 20 min at 97ºC using a PT Link (Dako-Agilent), 361	
or dewaxed and rehydrated and thereafter antigen retrieval was performed using a PT link 362	
(Dako-Agilent) for 20 min at 97ºC with citrate pH 6 buffer. Quenching of endogenous 363	
peroxidase was performed by 10 min with Peroxidase-Blocking Solution (Dako REAL S2023). 364	
Primary antibodies rabbit polyclonal anti-Ki67 (Thermo scientific; 1:75), rabbit polyclonal anti-365	
CD31 (Abcam ab28364; 1:500), mouse monoclonal anti-phospho-Histone H2A.X-pSer139) 366	
(clone JBW301, Millipore 05-636; 1:600), rabbit polyclonal anti-Cleaved Caspase-3 (Asp175) 367	
(Cell Signalling #9661; 1:300) and rabbit polyclonal anti-trophoblast specific protein alpha 368	
(Abcam ab104401; 1:1500) were incubated for 120 min at room temperature. BrightVision 369	
Poly-HRP-Anti Rabbit IgG Biotin-free (Immunologic, DPVR-110HRP) was used as a 370	
secondary antibody. Antigen–antibody complexes were revealed with 3-3′-diaminobenzidine 371	
(K3468, Dako), with the same time exposure per antibody (5 min). Sections were 372	
counterstained with hematoxylin (Dako, S202084) and mounted with Mounting Medium, 373	
Toluene-Free (CS705, Dako) using a Dako CoverStainer. Specificity of staining was 374	
confirmed by omission of the primary antibody. Slides were imaged using Olympus DP25 375	
camera mounted on Olympus BX45 microscope or using a E600 Nikon epifluorescence 376	
microscope equipped with 40x NA 0.75 objective lens and a charge-coupled Olympus DP72 377	
device camera. 378	
Histopathology 379	
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Embryos and placentas were harvested and fixed in 4% paraformaldehyde overnight at room 380	
temperature. Representative sections were trimmed, processed, embedded in paraffin, 381	
blocked, sectioned, and stained with H&E and periodic acid/Schiff reagent (PAS). Stained 382	
slides were examined microscopically, unbiased by 2 experienced board-certified pathologists 383	
(S.A.Y., A.d.B). The different types of trophoblastic cell lineage (i.e. labyrinth trophoblast, 384	
syncytiotrophoblast, giant cell trophoblast, and trophospongium) were identified based on the 385	
characteristic histologic features of every cell. The numbers and/or size of a particular cell 386	
from the trophoblastic cell lineage were compared between different genotypes and scored by 387	
an ordinal semi-quantitative system as described (48) where normal = no change in the 388	
numbers/size from control tissue, mild = decreased between 10-25% , moderate = decreased 389	
between 25-50%, and severe = the numbers and/or size of a particular cell type is 390	
decreased >50% when compared to control tissue. 391	
Isolation of RNA and quantitative real time PCR (qRT-PCR) 392	
Dissected tissue or primary MEFs were collected on ice, washed in PBS and snap frozen on 393	
dry ice. Tissues were disrupted in Tri-Reagent (Sigma) by zirconium beads in a mechanical 394	
tissue disruptor (Precellys 24, Bertin technologies). RNA was isolated by centrifugation 395	
followed by chloroform extraction, isopropanol precipitation, washing twice in 75% ethanol 396	
and resuspension in DEPC treated water. Nucleic acid quantification was performed with a 397	
Nanodrop 8000 instrument (ThermoScientific). Reverse transcription reaction was carried out 398	
using High Capacity RNA-to-cDNA Kit (ABI), following manufacturers instructions, in a 399	
reaction volume of 20ul and with the primers contained in the 2X RT buffer mix, which is 400	
composed of dNTPs, random octamers, and oligo(dT)16 and cDNA was stored at -20ºC. 401	
qPCR was performed using the comparative CT method and a Step-One-Plus real-time PCR 402	
Instrument (Applied Biosystems). SYBR Green and Taqman reactions were done in technical 403	
triplicate in a final volume of 10 µl. For SYBR Green 1X SYBR Green PCR Master Mix 404	
(#4364344, ABI), Forward and Reverse primer (Sigma; 100nM each) and 25 ng of template 405	
were used. For TaqMan reactions 1X TaqMan Universal PCR Master Mix (#4324018, ABI), 406	
0.5 µl of probe and 25 ng of template were used. Thermocycling parameters used were: for 407	
SYBR Green reactions (95ºC 20 sec; 40 cycles 95ºC 3 sec, 60ºC 30 sec; melting curve) and 408	
for TaqMan reactions (95ºC 20 sec; 40 cycles 95ºC 1 sec, 60ºC 20 sec). For TaqMan assays, 409	
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mACTB probe was used as an endogenous control for normalization and for SYBR Green 410	
assays, primers for 18S were used as endogenous controls for normalization. The 2−ddCT 411	
method was used for the analysis of the amplification products. Primer pairs used are 412	
indicated in Supplementary Table S7. Data are presented as the means ± standard deviation 413	
of at least 3 experiments, with at least 3 animals within each experimental group. Statistical 414	
significance was determined using an unpaired t-test (***p=<0.0001, **p=<0.001, * p=<0.05, 415	
n.s.= non significant).  416	
Affinity purification of TLK2 and quantitative mass spectrometry 417	
The human TLK2 cDNA was obtained in a Gateway compatible pENTR223 vector (Sigma 418	
Mission cDNA library) and introduced into the N-SF-TAP-DEST vector (a kind gift from J. 419	
Gloeckner(49)) by recombination reaction (300 ng TLK2-pENTR223, 300 ng N-SF-TAP DEST, 420	
4 µl Gateway® buffer (Invitrogen) and 4 µl clonase LR (Invitrogen)) and incubated 1 h at 25ºC. 421	
Proteinase K (2 µl) (Sigma) was added and incubated 10 min at 37ºC to stop the reaction. 422	
Competent E. coli DH5α (Sigma) were transformed with the resulting recombination reaction 423	
and selected with kanamycin. Plasmids were checked by restriction digests and sequencing 424	
(Macrogen) and DNA prepared with MaxiPreps (Promega). The kinase dead mutation (D592V) 425	
was introduced using QuickChange Lightning (Agilent). 426	
 427	
HEK293T cells were grown in DMEM (Life Technologies) supplemented with 10% fetal bovine 428	
serum (FBS) and penicillin/streptomycin at 37ºC in a 5% CO2 incubator. Transient 429	
transfections of 15 µg plasmid per 15 cm plate were carried out using polyethylenimine (PEI) 430	
(Polysciences Inc.). Cells were harvested 48 h after transfection and collected by 431	
centrifugation. Pellets were lysed in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 432	
1% Tween-20, 0.5% NP-40 with 1x protease inhibitor cocktail (Roche) and 1x phosphatase 433	
inhibitor cocktail (Sigma)) on ice for 20 minutes. Cells were freeze-thawed 3 times and lysates 434	
were cleared by centrifugation at 16K g for 20 min at 4ºC. Proteins were quantified using the 435	
DC Protein Assay (BioRad) and 100 µl was retained for input. Protein extracts were incubated 436	
with 100 µl pre-washed streptactin superflow resin (IBA) for 2 h at 4ºC using an overhead 437	
tumbler. Resin was spun down (7000xg for 30 s) and transferred to microspin columns (GE 438	
Healthcare). Resin was washed 3 times with 500 µl washing buffer (30 mM Tris, pH 7.4, 150 439	
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mM NaCl, 0.1% NP-40, protease and phosphatase inhibitors). Fusion proteins were eluted 440	
from the Strep-Tactin matrix with 500 µl of desthiobiotin elution buffer (IBA) (30 mM Tris, pH 441	
7.4, 150 mM NaCl, 1mM EDTA, 2 mM desthiobiotin, protease and phosphatase inhibitors) for 442	
10 min on ice. 150 µl was retained for Westerns and remaining protein was concentrated in 443	
centrifugal filter units and taken to a final concentration of 6M Urea, 100mM ammonium 444	
bicarbonate. Then they were reduced, alkylated, and digested to peptides using sequence-445	
grade trypsin at 1:10 ratio (w:w; enzyme:substrate) at 37ºC overnight. Tryptic peptide 446	
mixtures were desalted using a C18 UltraMicroSpin (ThermoFisher Scientific) column(50). 447	
 448	
Samples were analyzed in a LTQ-Orbitrap Velos Pro mass spectrometer (ThermoFisher 449	
Scientific) coupled to nano-LC (Proxeon) equipped with a reversed-phase chromatography 450	
12-cm column with an inner diameter of 75 µm, packed with 5 µm C18 particles (Nikkyo 451	
Technos Co., Ltd.). Chromatographic gradients from 93% buffer A, 7% buffer B to 65% buffer 452	
A, 35% buffer B in 60 min at a flow rate of 300 nl/min, in which buffer A: 0.1% formic acid in 453	
water and buffer B: 0.1% formic acid in acetonitrile. The instrument was operated in DDA 454	
mode and full MS scans with 1 micro scans at resolution of 60,000 were used over a mass 455	
range of m/z 250-2,000 with detection in the Orbitrap. Following each survey scan the top 456	
twenty most intense ions with multiple charged ions above a threshold ion count of 5000 were 457	
selected for fragmentation at normalized collision energy of 35%. Fragment ion spectra 458	
produced via collision-induced dissociation (CID) were acquired in the linear ion trap. All data 459	
were acquired with Xcalibur software v2.2. 460	
 461	
Acquired data were analyzed using the Proteome Discoverer software suite (v1.3.0.339, 462	
ThermoFisher Scientific) and the Mascot search engine (v2.3, Matrix Science) were used for 463	
peptide identification. Data were searched against an in-house generated database 464	
containing all proteins corresponding to human in the SwissProt database plus the most 465	
common contaminants, as previously described(51).  A precursor ion mass tolerance of 7 466	
ppm at the MS1 level was used, and up to three miscleavages for trypsin were allowed. The 467	
fragment ion mass tolerance was set to 0.5 Da. Oxidation of methionine and protein 468	
acetylation at the N-terminal were defined as variable modification. Carbamidomethylation on 469	
	 18	
cysteines was set as a fix modification. The identified peptides were filtered using a FDR < 470	
1%. For protein quantitation, the top3 method was used(52). In brief, the average of the 471	
peptide areas for the three most intense peptides per protein was used a measure of protein 472	
abundance. Additional data is presented in Supplementary Tables S1 to S4. 473	
BioID analysis of proximity interactions 474	
Human TLK2 was amplified with forward primer containing 5’ AscI (TLK2-AscI-475	
F:AAAAAAGGCGCGCCTATG-GAAGAATTGCATAGCC) or reverse primer  containing 3’ NotI 476	
restriction sites (TLK2-NotI-R: AAAAAAGCGGCCGCTTA-ATTAGAAGAACTGTT) using KOD 477	
Hot Start DNA Polymerase (Millipore) and cycling conditions recommended from the 478	
manufacturer (Polymerase activation at 95°C for 2 minutes, denaturation at 95°C for 20 479	
seconds, annealing at 55°C for 10 seconds and extension at 70°C for 50 seconds, repeated 480	
for 40 cycles). PCR products were purified using the PureLink Quick Gel Extraction Kit 481	
(Invitrogen) and cloned into pCR2.1-TOPO vector (Invitrogen). Top10 competent E. coli cells 482	
(Invitrogen) were transformed with pCR2.1-TLK2 and colonies were selected in carbenicillin. 483	
Constructs were verified by restriction digestion and sequencing (Macrogen) with primers for 484	
the TOPO vector (T7 Promoter-F and M13-R). Afterwards, TLK2 was cut from the pCR2.1-485	
TOPO vector by restriction digest with AscI (NEB) and NotI-HF (NEB), purified using the 486	
PureLink Quick Gel Extraction Kit (Invitrogen) and ligated into pcDNA5/FRT/TO-N-FLAG-487	
hBirA* (TLK2) using Quick Ligation Kit (BioLabs). Top10 competent E. coli cells (Invitrogen) 488	
were transformed with pcDNA5/FRT/TO-N-Flag-hBirA*-TLK2 vector and carbenicillin selected. 489	
The constructs were confirmed by restriction digestion with AscI (NEB) and NotI-HF (NEB) 490	
and sequencing (Macrogen). 491	
 492	
AD293 cells were seeded and transfected the next day with either pcDNA5/FRT/TO-N-FLAG-493	
hBirA*-TLK2 or pcDNA5/FRT/TO-N-FLAG-hBirA* using PEI (Sigma) +/- 50µM biotin (IBIAN 494	
Biotechnology 2-1016-002). For mass spectrometry, 5x15cm plates per condition were 495	
harvested 24 hours post-transfection by scraping cells into PBS, washing 2X in PBS and snap 496	
freezing on dry ice. Cell pellets were lysed in 5 ml modified RIPA buffer (1% TX-100, 50 mM 497	
Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1%SDS, 0.5%Sodium 498	
deoxycholate and protease inhibitors) on ice, treated with 250 U benzonase (EMD Millipore) 499	
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and biotinylated proteins were isolated using streptavidin-sepharose beads (GE). Proteins 500	
were washed in Ammonium bicarbonate and digested with trypsin. Mass spectrometry was 501	
performed as previously described(53). Additional data is presented in Supplementary Tables 502	
S5 and S6. 503	
Endogenous co-immunoprecipitation 504	
Dissected placentas were collected on ice and disrupted in Extraction Buffer (300 mM NaCl, 505	
0.5% NP-40, 50 mM Tris pH 7.8, 0.2 mM EDTA, 5% glycerol, 1x protease (Roche) and 506	
phosphatase inhibitors (Sigma)) by zirconium beads in a mechanical tissue disruptor 507	
(Precellys 24, Bertin technologies). After two centrifugation steps (10  min, max speed, 4 °C 508	
and 5 min, max speed, 4ºC), supernatants were collected, precleared, and 509	
immunoprecipitated (overnight, 4 °C, on rotation) with 10  µg of anti-TLK2 antibody (Bethyl 510	
Laboratories A301-257A), 10 µl of polyclonal ASF1 serum (generated in the Groth laboratory) 511	
or 10  µg of rabbit IgG (Sigma) bound to 50  µl of Dynabeads Protein G (Invitrogen). Beads 512	
were washed five times with cold Wash Buffer (150mM NaCl, 0.2% NP-40, 50mM Tris pH 7.8, 513	
0.2 mM EDTA, 5% glycerol, 1x protease (Roche) and phosphatase inhibitors (Sigma)), 514	
resuspended in 30 µl of Laemmli Sample Buffer and boiled for 20 min.  515	
Protein extraction for Western blotting 516	
Dissected tissues or cells were collected on ice, washed in PBS and resuspended in TNG-517	
150 buffer (50 mM Tris/Hcl, 150 mM NaCl, 1% Tween-20, 0.5% NP-40, 1x protease (Roche) 518	
and phosphatase inhibitors (Sigma)). Tissues were disrupted by zirconium beads in a 519	
mechanical tissue disruptor (Precellys 24, Bertin technologies). Protein concentration was 520	
quantified using the DC Protein Assay (Biorad), separated by SDS-PAGE and transferred to 521	
PVDF membrane (Millipore). Membranes were probed with antibodies for TLK1 (Cell 522	
Signaling 4125, 1:1000), TLK2 (Bethyl Laboratories A301-257A, 1:1000), ASF1 (Sigma 523	
A5236, 1:800, for HEK-293T human cells; Groth laboratory rabbit polyclonal, 1:2000, for 524	
mouse tissue and MEFs)(14), Actin (Sigma A4700, 1:3000), FLAG (Sigma F3165, 1:1000), 525	
LC8 (Abcam ab51603, 1:1000), GAPDH (Millipore MAB374, 1:10000) and p-ASF1 S166 526	
(Groth laboratory rabbit polyclonal, 1:30000)(11). Primary antibodies were detected with 527	
appropriate secondary antibodies conjugated to HRP and visualized by ECL-Plus (GE).  528	
Analysis of genomic instability 529	
	 20	
For colony formation assays, cells were seeded in duplicate on 6-cm plates and the number 530	
of seeded cells adjusted to the plating efficiency. Cells were incubated at 37ºC for 10-14 days 531	
and colonies stained with crystal violet (Sigma-Aldrich) and counted using ImageJ-plugin 532	
Trainable Weka Segmentation. For immunofluorescence and high-throughput microscopy 533	
(HTM), MEFs were grown in LabTek II Chamber slides (Labclinics). Cells were pre-extracted 534	
for 5 min in 0.2% TX-100/PBS on ice and fixed for 10 min in 4% paraformaldehyde at room 535	
temperature. Fixed cells were blocked in 3% BSA with 0.1%Tween/PBS for 1 h and stained 536	
using standard procedures. For HTM, 48 images were automatically acquired per well with a 537	
Scan^R (Olympus) at 40× magnification and non-saturating conditions. Images were 538	
segmented using the DAPI staining to generate nuclei masks from which the corresponding 539	
signals were calculated using an in-house–developed package based on Cell Profiler. For 540	
immunofluorescence analysis the antibody anti-γH2AX (sc-101696, Santa Cruz) and the 541	
corresponding secondary antibody conjugated with Alexa Fluor 568 were used. For 542	
metaphase spread preparations, cells were treated with colcemid (0.1 g/ml for 2 h). Cells 543	
were trypsinized, hypotonically swollen in 0.075 M KCl for 20 min at 37ºC and fixed (75% 544	
MeOH and 25% acetic acid, ice cold). Metaphase preparations were spread on glass slides 545	
and stained with DAPI in Vectashield mounting medium. Images were taken using a Leica 546	
DM6000 microscope and analyzed using Fiji software. 547	
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FIGURE LEGENDS 728	
Figure 1. TLK1 is dispensable for murine development. (A) Schematic of the Tlk1 genetrap 729	
allele (Tlk1T). The position of the Flex-vector genetrap cassette in the Tlk1 locus and 730	
approximate positions of primers used for quantitative real time PCR are shown. (B) The 731	
genetrap clone was screened for single copy insertion using a probe for the neomycin 732	
cassette in a Southern blot of EcoRV digested genomic DNA. A single band of the expected 733	
size was observed (red arrow). GTF2 is an unrelated line with a neomycin cassette (positive 734	
control) and C57BL6 is wild type genomic DNA (negative control). (C) Quantitative real time 735	
PCR analysis of Tlk1 and Tlk2 levels in mouse embryonic fibroblast (MEF) cultures derived 736	
from littermates of the indicated gentoype. The mean (red bar) and standard deviation (SD) of 737	
3 replicates are plotted. (D) Western blotting of TLK1 and TLK2 protein levels in MEF cultures 738	
of the indicated genotype. Ponceau red stained blot showed equal loading. (E) Tlk1T/T mice 739	
are born at the expected (exp.) Mendelian ratios. Numbers of pups of the indicated genotype 740	
observed (obs.) from 32 litters of Tlk1+/T mice (110 pups total) are indicated. Percentage 741	
observed is indicated above the bar graphs. (F) Normal weight and growth of Tlk1T/T mice. 742	
Weights of littermate animals at 18 and 30 days post partum are plotted with the mean (red 743	
bars) and SD indicated (n=16 for Tlk1+/+and 15 forTlk1T/T respectively). (G) Normal survival of 744	
Tlk1T/T mice. Kaplan Meier plot of animal survival over 18 months (n=25, 41 and 26 for Tlk1+/+, 745	
Tlk1+/T and Tlk1T/T respectively). (H) Normal litter sizes are observed in Tlk1T/T female mice of 746	
2-5 months of age compared to wild type of heterozygous littermates (n=20, 11 and 11 for 747	
Tlk1+/+, Tlk1+/T and Tlk1T/T respectively). The mean (red bars) and SD are plotted and 748	
statistical analysis using the Wilcoxon Rank Sum test indicated no significant differences 749	
(p=0.65;Tlk1+/+vs.Tlk1+/T, 0.75; Tlk1+/+vs.Tlk1T/T and 0.52; Tlk1+/Tvs.Tlk1T/T). (I) TLK1 protein 750	
levels in thymocytes of the indicated genotype are shown. Actin serves as a loading control. 751	
(J) Analysis of T-cell subsets in 2-month old animals of the indicated genotype (n=3 per 752	
genotype, each in triplicate). The mean (red bars) and SD are shown and representative flow 753	
cytometry data showing CD4 and CD8 staining of CD3 positive T-cells is shown in the right 754	
panel. 755	
 756	
	 28	
Figure 2. TLK2 is an essential gene. (A) Schematic of the Tlk2 knockout first allele (Tlk2T). 757	
The position of the genetrap cassette, the allelic configurations and their designations 758	
following FLP and CRE expression are shown. (B) Southern blot of SpeI digested genomic 759	
DNA with a probe for Neomycin to identify clones with single insertions. 6 targeted clones and 760	
a negative control (C57BL/6) are shown and the expected size indicated. Additional 761	
Southerns confirming correct targeting are shown in Supplementary Figure S1. (C) Tlk2 762	
deficiency is embryonic lethal. The number of animals expected (exp.) from 27 Tlk2+/T 763	
breedings (112 pups total) assuming normal Mendelian inheritance is shown compared to the 764	
number of observed pups (obs.). Percentage observed is indicated above the bar graphs. 765	
Based on the genotypes of a total of 112 pups from 14 independent litters, a p-value of 766	
<0.0001 was determined using binomial distribution and indicated by ***. (D) Normal 767	
Mendelian distribution of genotypes was observed amongst 41 E10.5 to E13.5 embryos from 768	
6 individual Tlk2+/T breedings. Percentage observed is indicated above the bar graphs. (E) 769	
Examples of littermate E10.5 embryos (scale bar = 1mm) (F) E12.5 embryos (scale bar = 770	
1mm) (G) E15.5 embryos (scale bar = 2mm) and (H) E16.5 embryos (scale bar = 2mm). (I) 771	
Quantitative real time PCR analysis of Tlk1 and Tlk2 levels in MEFs from littermates of the 772	
indicated genotype. The mean (red bars) and standard deviation (SD) of 3 replicates are 773	
plotted. (J) Western blotting of TLK1 and TLK2 protein levels in MEFs of the indicated 774	
genotype. Histone H3 is shown as a loading control and a non-specific (NS) band recognized 775	
by the TLK2 antibody is indicated. (K) H&E (left panels) or Ki67 immunohistochemical staining 776	
(right panels) of E12.5 embryo sections of the indicated genotype (scale bar = 1 mm). 777	
 778	
Figure 3. TLK2 is required for placental development. (A) Semi-quantitative analysis of 779	
histological phenotypes in Tlk2-/- placentas. In each case, Tlk2-/- placentas (n=10) at the 780	
indicated age were compared to wild type littermates. Phenotypes are abbreviated as follows: 781	
Placental thickness (Pl.Th), numbers/size of Labyrinth trophoblasts (LT), Syncytiotrophoblasts 782	
(Syn.T), Spongiotrophoblasts including glycogen cells (TS), Giant cell trophoblasts (Gi.T) and 783	
Vasculature (Vas). Summary of the grading system used (48) provided in the Materials and 784	
Methods. (B) Sections from E11.5 and E12.5 littermate placentas stained with H&E. Tlk2-/- 785	
placentas are thinner, less cellular and poorly vascularized compared to Tlk2+/+. Scale bars = 786	
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500 microns. (C) CD31 staining reveals that the vasculature of Tlk2-/- placentas is 787	
miniaturized, collapsed and appears slit-like (red arrowheads) compared to the well-788	
developed, widely opened vasculature of Tlk2+/+ (blue arrowheads). Scale bar = 20 microns. 789	
(D) H&E staining from the indicated age and genotype showing fewer and smaller 790	
trophoblasts (arrows) and Syncytiotrophoblasts (blue arrowheads) with an absence of fetal 791	
vasculature (red arrowhead) in Tlk2-/- placentas. Scale bar = 20 microns. (E) H&E staining of 792	
placentas showing a thinner Trophospongium (Spongiotrophoblasts and glycogen cells) in 793	
Tlk2-/- placentas. The Trophospongium (TS), labyrinth (L) and decidua (D) are indicated. 794	
Scale bar = 50 microns. 795	
 796	
Figure 4. Proliferation and gene expression in placentas lacking TLK2. (A) 797	
Immunohistochemical staining of the proliferative marker Ki67 or (B) the DNA double-strand 798	
break marker γH2AX in E10.5, E11.5 and E12.5 placentas of the indicated genotype. Similar 799	
numbers of proliferative cells are visible in the labyrinth of Tlk2-/- placentas compared to wild 800	
type at each stage. Mean percent positive cells (red bars) and SD is graphed in right panels. 801	
n=3 and 2 at E10.5, n=3 and 3 at E11.5 and n=5 and 6 at E12.5 for Tlk2+/+and Tlk2-/-, 802	
respectively. At least 200 total cells were counted for each individual and scale bar in (A) = 10 803	
microns and in (B) = 100 microns. (C) and (D) Quantitative real time PCR analysis of genes 804	
expressed in trophoblast lineages from E12.5 placenta samples. Combined data represents 805	
the mean of triplicate samples from 3 individual animals of each genotype. Statistical 806	
significance was determined using an upaired t-test (***p=<0.0001, **p=<0.001, * p=<0.05). 807	
(E) Immunohistochemical staining for Tpbpa reveals a thinner trophospongium (TS) in the 808	
absence of TLK2 at both E10.5 and E12.5. The orientation of the labyrinth (L) is also 809	
indicated. Quantification of signal intensity distribution in the TS is shown in the right panel, 810	
normalized to area. Scale bar = 500 microns. 811	
 812	
Figure 5. TLK2 interacts with ASF1 and influences its phosphorylation in the placenta. (A) 813	
Quantitative real time PCR of Tlk1 and Tlk2 in wild type placentas of the indicated age. Mean 814	
(red bars) and SD of triplicate samples is graphed (n=1, 3 and 1 for each age indicated). (B) 815	
Western blotting of TLK1, TLK2 and ASF1 in lysates from E13.5 placenta (Pon. = Ponceau 816	
	 30	
red stained membrane). TLK2 levels are similar in either tissue (placenta = Pla. and 817	
heart/fetal liver = h-l) while TLK1 levels are much higher in embryonic tissue relative to 818	
placenta. Samples from 2 littermate wild type placentas are shown. Additional examples are 819	
shown in Supplementary Figure S4B. (C) Graphic depiction of the combined results from 820	
multiple proteomics approaches to identify TLK2 interacting proteins from HEK293T or AD293 821	
cells (IP-MS and BioiD approaches and data are described in further detail in Supplementary 822	
Figure S5 and Supplementary Tables S1-S6). TLK1, ASF1a, ASF1b and DYNLL1 (LC8) are 823	
the only high confidence interacting proteins identified. LC8 does not appear to be a substrate 824	
of TLK2 (Supplementary Figure S5G and S5H). (D) Reduced ASF1-S166 phosphorylation (p-825	
ASF1) in the E12.5 and E13.5 Tlk2-/- placentas. Western blotting of lysates for TLK2, ASF1 826	
and p-ASF1 from littermates of the indicated age. In each case, blots shown are from the 827	
same membrane (Pon. = Ponceau red stained membrane). Quantification of p-ASF1/ASF1 828	
levels in multiple samples of the indicated genotype is shown in the right panel (additional 829	
Western examples are shown in Supplementary Figure S6A). Statistical significance 830	
(p=0.0064) was determined using an unpaired t-test and the mean (red bars) and SD are 831	
indicated (n=14 and 11, respectively). (E) Co-immunoprecipitation of endogenous TLK2 and 832	
ASF1 from wild type E13.5 placental lysates using antibodies for ASF1 (top panels) or TLK2 833	
(bottom panels). (Pon. = Ponceau red stained membrane). Additional examples are shown in 834	
Figure S6B. 835	
 836	
Figure 6. TLK2 is dispensable in embryonic and adult tissues. (A) Tlk2+/+ and Tlk2-/- 837	
littermates are shown from breedings of femaleTlk2+/-, Sox2-Cre+ and male Tlk2+/F mice. (B) 838	
Weight of mice lacking TLK2 is slightly reduced but growth is similar to wild type. Mean (red 839	
bars) and SD are indicated (n=20 and 9 for 1 mo., n=10 and 7 for 2 mo., n=6 and 5 for 3 mo., 840	
n=5 and 4 for 4 mo. for Tlk2+/+ and Tlk2-/-, respectively) (C) Kaplan Meier survival curve of 841	
mice with the indicated genotypes (Tlk2+/-n=42, Tlk2-/- n=26). (D) Western blotting of TLK1 842	
and TLK2 using lysates from selected tissues of Tlk2+/+ and Tlk2-/- mice. NS refers to a non-843	
specific band observed with the TLK2 antibody in many tissues and cell lines. (E) Similar 844	
expression patterns of Tlk1 and Tlk2 in adult mice. Taqman real time PCR analysis of Tlk1 845	
and Tlk2 mRNA levels (Log2 transformed) relative to ActB. Mean (blue bars for Tlk1 and red 846	
	 31	
bars for Tlk2) and SD of triplicate reactions from at least 2 animals are plotted. In each case, 847	
levels are normalized to that of the liver (set to 1). (F) Western blotting of TLK1/2 protein 848	
levels in 2-month old male and female wild type tissues. GAPDH is shown as a loading 849	
control. (G) Examples of littermate Tlk1T/T Tlk2+/+ and Tlk1T/T Tlk2+/T animals at different ages. 850	
All Tlk1T/T Tlk2+/T animals (n=4) observed were severely runted and 1 lacked limbs on the left 851	
torso. All mice were sacrificed prior to 1 month following veterinary advice due to lack of 852	
mobility and trembling. A Kaplan Meier survival plot for all related genotypes is presented in 853	
Supplementary Figure S7. 854	
 855	
Figure 7. TLK1 and TLK2 cooperate to maintain cell viability and chromosome stability. (A) 856	
Western Blot with antibodies against TLK1 and TLK2 in whole cell extracts of transformed 857	
MEFs of the indicated genotypes mock treated or treated with 4OHT to induce trapping of 858	
TLK1 and/or deletion of TLK2 (Pon. = Ponceau red stained membrane). (B) Deletion of TLKs 859	
reduces colony formation. MEFs were mock treated or treated with 4OHT for 72h, washed, 860	
plated and cultured for 10-14 days. Relative colony number to mock treated cells is displayed. 861	
Tlk1+/+ Tlk2+/+ Cre+/- n= 3; Tlk1C/C Tlk2F/- Cre+/- n=6; Tlk2F/- Cre+/- n=6. Results are shown as 862	
mean±  SEM. Experiment was performed in technical duplicates, at least in biological 863	
triplicate. Statistical significance was determined using an upaired t-test (****p=<0.0001, 864	
***p=<0.001). (C) Representative images of IF experiments staining for γH2AX are shown 865	
from Tlk1T/T Tlk2F/- cells that were mock treated or treated with 4OHT. Nuclei were 866	
counterstained with 4′,6-diamidino- 2-phenylindole (DAPI). (D) Increased DNA double-strand 867	
break formation following the depletion of TLK1 and TLK2. High throughput microscopy of 868	
γH2AX levels per individual nucleus in response to TLK depletion in MEFs mock treated or 869	
treated with 4OHT. At least 800 nuclei were quantified per condition. Mean is shown as a red 870	
line; a.u., arbitrary units. Statistical significance was determined using Ordinary one-way 871	
ANOVA Tukey's multiple comparisons test (****p=<0.0001). (E) Increased chromosome 872	
bridges are evident in 4OHT induced double TLK deficient cultures relative to mock treated or 873	
Tlk2 deletion alone. A minimum of 200 cells was scored in each independent experiment. 874	
Tlk1+/+ Tlk2+/+ Cre+/- n= 2; Tlk1C/C Tlk2F/- Cre+/- n=5; Tlk2F/- Cre+/- n=4. Results are shown as 875	
mean±SD. Statistical significance was determined using an upaired t-test (*p=<0.05). (F) Plot 876	
	 32	
of chromosomal aberration types scored from multiple transformed MEF cultures depicted as 877	
percent aberrations per chromosome. Results are shown as mean±  SEM. Statistical 878	
significance was determined using Fisher’s exact test (****=p<0.0001). (G) Western blotting of 879	
Tlk1C/C Tlk2F/- MEF lysates mock treated or treated with 4OHT for TLK1, TLK2, ASF1 and p-880	
ASF1. Experiment performed in biological triplicate and a representative example shown. (H) 881	
Proposed model for the contribution of TLK1 and TLK2 activity to the placenta and adult 882	
tissues. In the placenta, and possibly other cell types or tissues, TLK2 is the prevalent activity 883	
and is required to maintain a threshold of signalling required for viability. This likely involves 884	
ASF1a/b and potentially other substrates. In most adult tissues, TLK1 and TLK2 are largely 885	
redundant and the presence of either is sufficient to provide the necessary activity to support 886	
cellular functions required for the maintenance of genome integrity and viability. 887	
 888	
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Supplementary Figure Legends 
Figure S1. Generation of Tlk2 conditional knockout mice. (A) Following transfection and 
neomycin selection, ES clones were screened by long range PCR for correct targeting. Clone 
IDs are indicated below and the expected band for the targeted allele indicated in red. 
C57BL/6 refers to wild type genomic DNA (negative control). (B) Southern blotting of KpnI 
digested genomic DNA from targeted ES cell clones selected by long range PCR. The 5P 
probe recognizes a 12.5 kb fragment and the 3P probe recognizes a 14 kb fragment in the 
correctly targeted locus. The untargeted locus gives a 26 kb band in both cases. For the Neo 
probe, we digested with SpeI to recognize a 10.5 kb fragment (Figure 2B). Expected size of 
recombined products with probes for the 5’ and 3’ homology arms are indicated (red 
arrowhead). Clone IDs are indicated above the lanes. Additional details regarding the 
generation and screening of targeted ES cells are available upon request. 
 
Figure S2. Growth retardation of Tlk2T/T E12.5 embryos. PFA fixed embryos were embedded 
in a 0.8% agarose block before optical clearing, dehydrated in 100% methanol for 24 hours 
and transferred into Murray’s Clear (BABB: Benzyl Alcohol Benzyl Benzoate) for at least 2 
days before imaging. Whole mount imaging of specimens was performed with a custom-built 
lightsheet system, at 1.32X with a macroscope detection unit AZ100M (Nikon, Japan) for 
autofluorescence with a 488nm laser forming a lighsheet of about 12 microns thickness, 
incident from the left of the image and flat across the whole field of view (zoom: 1.32x, 
colored in 'Orange Hot' Look-up-Table). The images were recorded with an ORCA R2 CCD 
camera (Hamamatsu, Japan). Image stacks were stitched vertically with ImageJ. The 4 
planes (from left to right) show different depths through the whole embryos (2, 4, 6 and 7.2 
mm respectively) from the dorsal surface. The embryos are mounted to face the camera 
dorsally.  
 
Figure S3. Analysis of TLK2 deficient placentas. (A) Reduced size and vascularization of 
Tlk2T/T placenta compared to a wild type littermate. (B) Lack of blood circulation in the 
umbilical cord (red arrowhead) of an E14.5 Tlk2T/T embryo. (C) Representative PCR analysis 
of the deletion of Tlk2 Exon 4 following Sox2-Cre expression, genotypes are indicated and 
shown schematically to the right. (D) CD31 staining of E11.5 and E12.5 placentas of the 
indicated genotypes. Areas cropped and presented in Figure 3C are indicated. Scale bar is 
20 microns. (E) Sections from E10.5 placentas stained with H&E. Tlk2-/- placentas are thinner, 
less cellular and poorly vascularized compared to Tlk2+/+. Fewer numbers of labyrinth 
trophoblast (black arrows) and syncytiotrophoblasts (blue arrows) are present in Tlk2-/- 
placentas. L=labyrinth, TS=trophospongium and D=decidua in all panels. Scale bar in 
10X=100 microns and in 20X=50 microns. (F) The E11.5 Tlk2+/+ labyrinth (L) is well 
vascularized, has widely opened sinusoids and is composed of many well-developed 
trophoblasts (black arrows) and syncytiotrophoblasts (blue arrows). The Tlk2-/- labyrinth is 
poorly vascularized, has collapsed or has very narrow sinusoids and is composed of fewer 
and smaller trophoblasts (black arrows) and syncytiotrophoblasts (blue arrows). Also the Tlk2-
/- trophospongium (TS) is significantly thinner compared to Tlk2+/+ and lacks glycogen 
trophoblasts. Scale bar in 10X=100 microns and in 20X=50 microns. (G) Lower magnification 
images of E11.5 placentas presented in Figure 3D from the indicated genotypes. Boxed 
regions indicate cropped regions in main figure. Scale bars are 20 microns. (H) Sections from 
E12.5 placentas stained with H&E. The Tlk2+/+ placenta has a histologically normal labyrinth 
(L) that is well vascularized and is composed of many mature trophoblasts discerned by their 
large spherical nuclei (black arrows). In contrast, the Tlk2-/- labyrinth is composed of clusters 
of small, undifferentiated hyperchromatic trophoblasts that tend to arrange in clusters or 
aggregates (arrowheads). Also the trophospongium (TS) zone of the Tlk2-/- placenta appears 
thinner and lacks glycogen trophoblasts. Scale bar in 10X=100 microns and in 20X=50 
microns. (I) Lowerr magnification images of E12.5 placentas presented in Figure 3D from the 
indicated genotypes. Boxed regions indicate cropped regions in main figure. Scale bars are 
20 microns. (J) The E15.5 Tlk2-/- labyrinth (L) is collapsed, lacks vasculature, has fewer 
trophoblasts (black arrows), and exhibits increased deposition of extracellular matrix 
(asterisks) when compared to the highly vascularized Tlk2+/+ labyrinth. Scale bar in 10X=100 
microns and in 20X=50 microns. 
 
Figure S4. Histochemical and protein analysis. (A) Immunohistochemical staining of the 
cleaved caspase-3 apoptosis marker in littermate E10.5, E11.5 and E12.5 placentas of the 
indicated genotype (n=3 and 2 at E10.5, n=3 and 3 at E11.5 and n=5 and 6 at E12.5 for 
Tlk2+/+and Tlk2-/-, respectively. At least 200 total cells were counted for each individual). .Few 
positive cells were observed regardless of genotype or developmental stage. Quantification of 
percent positive cells is graphed in the right panels with mean and standard deviation 
indicated. (B) Western blotting of lysates from embryonic tissue (fetal heart and liver = L) and 
placenta (P) from littermate animals of the indicated genotypes. While TLK2 protein levels are 
similar between tissues, TLK1 protein levels are much higher in the embryonic tissues relative 
to placenta. 
 
Figure S5. Proteomic approaches to identify TLK2 interacting proteins by mass spectrometry. 
(A) Schematic of affinity purification strategy (IP-MS) for Strep-FLAG tagged TLK2 or a kinase 
dead allele, TLK2-KD (D592V). Replicates of the affinity purifications were digested with 
trypsin and subjected to LC-MS/MS to quantitatively identify interacting proteins. (B) 
Schematic of the BioID approach using TLK2 fused to the promiscuous biotin ligase BirA*. (C) 
Validation of TLK2 or TLK2 KD expression and affinity purification of TLK2 by Western 
blotting following transfection of AD293 cells (bottom panel). The effectiveness of the kinase 
dead mutation was also validated in IP-kinase assays (top panel). The TLK2 KD mutation 
abolished autophosphorylation and substrate phosphorylation (Myelin Basic Protein: MBP). 
(D) Validation of BirA*-TLK2 expression and activity in AD293 cells supplemented with biotin. 
Note that Streptavidin signal that was detected in the nucleus and cytoplasm for the BirA*-
FLAG control, was exclusively nuclear in the case of BirA*-FLAG-TLK2. Biotinylated peptides 
were purified from cells expressing the BirA* constructs and identified by LC-MS/MS. (E) 
Validation of high confidence interacting proteins by IP-Western. Data is summarized in 
Figure 5C and presented in full in Supplementary Tables S1 to S4. The only proteins 
identified that were not detected in any controls and present in all 6 TLK2/TLK2-KD replicates 
were TLK1, ASF1a, ASF1b, LC8 (DYNLL1) and RPS11 (Supplementary Table S2). Of these, 
all but RPS11 were also found highly enriched in the BioID experiments (Supplementary 
Table S5 and S6). We could readily validate the interactions between TLK2 and endogenous 
TLK1 and ASF1 in HEK293Ts. In addition, we could detect binding to endogenous LC8. (F) 
Validation of ASF1a as a TLK2 substrate. IP-kinase assays were performed with TLK2 or 
TLK2 KD affinity purified from HEK293T cells using GST-ASF1a as a substrate. (G) Addition 
of LC8 did not influence the kinase activity of TLK2 (based on autophosphorylation) and 
recombinant LC8 was not phosphorylated by TLK2, suggesting that it is unlikely to be a 
substrate. (H) Kinetic analysis of TLK2 or TLK KD activity on MBP and LC8. MBP 
phosphorylation is clearly increased over time while no signal is observed for LC8 in the 
phosphorimager, despite similar levels of protein loaded. 	
Figure S6. Analysis of ASF1 levels and interaction with TLK2. (A) Analysis of total ASF1 and 
ASF1-pS166 (p-ASF1) levels in placentas from the indicated genotypes and age. Western 
blotting results from 3 different gels/transfers are shown. Compiled quantification of all 
samples is shown in Figure 5D. ID codes indicate the litter number and embryo number, Tlk2-
/- placentas are indicated in green font. (B) Additional example of ASF1 Westerns following IP 
of endogenous TLK2 from placental extracts (related to main Figure 5E). Both TLK1 and 
ASF1 consistently interact with TLK2 in IPs. A non-specific band is indicated by “ns”. 	
Figure S7. Kaplan Meier survival curve of all genetrap allelic configurations observed to date. 
The number of animals represented is shown in parentheses. 	
